Septic Shock
📧 Sign up to get email alerts when something new happens for Septic Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Epirubicin for the Treatment of Sepsis & Septic Shock [Phase 2]
Phase 2 clinical trial evaluating epirubicin for sepsis and septic shock is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Oral Bedtime Melatonin in Critically Ill Patients [Phase 4]
Phase 4 trial evaluating oral bedtime melatonin in critically ill patients; current status unknown.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock [Phase 3]
Phase 3 trial update on vitamin C, hydrocortisone, and thiamine in patients with septic shock; trial terminated.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Vitamin C Deficiency in Septic Shock [Phase 4]
Phase 4 clinical trial assessing vitamin C deficiency in septic shock has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments [Phase 3]
Phase 3 trial investigating early intravenous vitamin C in patients with sepsis or septic shock in emergency departments has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Esomeprazole to Reduce Organ Failure in Sepsis [Phase 3]
A Phase 3 trial evaluating esomeprazole for reducing organ failure in patients with sepsis and septic shock has completed.
-
CLINICAL_TRIALS withdrawal · 2024-01-18Clinical Trial Update: Vitamin C to Reduce Vasopressor Dose in Septic Shock [Phase 3]
Phase 3 trial investigating vitamin C to reduce vasopressor dose in septic shock has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS [Phase 2]
A Phase 2 clinical trial evaluating the dose-response relationship of fludrocortisone in septic shock has completed.
-
CLINICAL_TRIALS withdrawal · 2024-01-11Clinical Trial Update: Midodrine in the Recovery Phase of Septic Shock [Phase 3]
A Phase 3 clinical trial of midodrine in the recovery phase of septic shock was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock. [Phase 4]
Phase 4 clinical trial evaluating combined vitamin therapy for septic shock has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Adjunctive Esketamine for Analgesia in Mechanically Ventilated Septic Shock Patients [Phase 3]
A Phase 3 trial investigating adjunctive esketamine for analgesia in mechanically ventilated septic shock patients is in progress with unkno…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients [Phase 2, Phase 3]
Clinical trial investigating the hemodynamic effects of fludrocortisone on pressor response to norepinephrine in septic shock, currently sus…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients [Phase 2]
Phase 2 clinical trial update for VBI-S aiming to treat hypotension in hypovolemic septic shock patients is reported as ongoing with unknown…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Heamodynamic Effects of Paracetamol in Septic Shock Patients [Phase 4]
Phase 4 trial update evaluating the hemodynamic effects of paracetamol in patients with septic shock and sepsis.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation [Phase 1, Phase 2]
A two-phase clinical trial evaluated the effect of bronchoscopy on outcomes in patients with severe sepsis, ARDS, septic shock, and prolonge…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Effect of Bronchoscopy on the Outcome of Patients With Severe Sepsis With ARDS and Complicated by VAP From Prolonged Ventilation [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluated bronchoscopy in patients with severe ARDS and septic shock complicated by ventilator-associated pneumon…
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock [Phase 3]
A Phase 3 pilot trial evaluated the use of hydrocortisone, vitamin C, and thiamine in patients with sepsis and septic shock; the study has c…
-
FDA approval · 2023-09-29FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)
The FDA granted approval for Baxter’s vasopressin in 0.9% sodium chloride under an Original Application (NDA).
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Thyroid Hormone Supplementation in Patients With Septic Shock [Phase 2]
Phase 2 trial update on thyroid hormone supplementation in patients with euthyroid sick syndrome and septic shock has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock [Phase 2]
Pilot Phase II study assessing hemodynamic tolerance and anti-inflammatory effects of esmolol during treatment of septic shock.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients [Phase 3]
Phase 3 trial update on selective decontamination of the digestive tract in ICU patients with critical illness and sepsis.
-
FDA approval · 2023-07-21FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis [Phase 3]
A Phase 3 trial evaluating crystalloid liberal versus vasopressor early resuscitation in septic shock has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality [Phase 4]
Phase 4 trial exploring the role of ulinastatin in preventing severe sepsis, septic shock, and related morbidity and mortality.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients [Phase 4]
Phase 4 clinical trial update on an intelligent decision-oriented hemodynamic therapy system for septic shock patients.